Experience with intravenous immunoglobulin in severe childhood atopic dermatitis

Allergologia et Immunopathologia

Volumn 40, Issue 2, 2012, Pages 131-133

  Ozen, Ahmet ^a   Baris, Safa ^a   Karakoc Aydiner, Elif ^a   Yucelten, Deniz ^a   Nadir Bahceciler, Nerin ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CALCINEURIN INHIBITOR; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ATOPIC DERMATITIS; CASE REPORT; CHILD; CHILDHOOD DISEASE; DERMATOPHAGOIDES; DISEASE CONTROL; DISEASE DURATION; DISEASE SEVERITY; DRUG TREATMENT FAILURE; EGG; EGG ALLERGY; EOSINOPHIL COUNT; FEMALE; HUMAN; IMMUNOTHERAPY; LETTER; MALE; MILK; MILK ALLERGY; MULTIPLE CYCLE TREATMENT; PRICK TEST; REMISSION; SCHOOL CHILD; STEROID THERAPY; TREATMENT DURATION;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; CHILD; DERMATITIS, ATOPIC; DESENSITIZATION, IMMUNOLOGIC; DISEASE PROGRESSION; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; MALE; PYROGLYPHIDAE; REMISSION INDUCTION; YOUNG ADULT;

EID: 84857656836     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2011.04.007     Document Type: Letter

References (9)

1. Prins C., Gelfand E.W., French L.E. Intravenous immunoglobulin: properties, mode of action and practical use in dermatology. Acta Derm Venereol 2007, 87:206-218.
2. Leung D.Y.M. Atopic dermatitis: immunobiology and treatment with immune modulators. Clin Exp Immunol 1997, 107(Suppl. 1):25-30.
3. Noh G., Lozano F. Intravenous immune globulin effects on serum-soluble CD5 levels in atopic dermatitis. Clin Exp Allergy 2001, 31:1932-1938.
4. Takei S., Arora Y.K., Walker S.M. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J Clin Invest 1993, 91:602-607.
5. Paul C., Lahfa M., Bachelez H., Chevret S., Dubertret L. A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis. Br J Dermatol 2002, 147:518-522.
6. Jolles S., Sewell C., Webster D., Ryan A., Heelan B., Waite A., et al. Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts. Acta Derm Venereol 2003, 83:433-437.
7. Noh G., Lee K.Y. Intravenous immune globulin (i.v.IG) therapy in steroid-resistant atopic dermatitis. J Korean Med Sci 1999, 14:63-68.
8. Jolles S. A review of high-dose intravenous immunoglobulin treatment for atopic dermatitis. Clin Exp Dermatol 2002, 27:3-7.
9. Belloni B., Ziai M., Lim A., Lemercier B., Sbornik M., Weidinger S., et al. Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels. J Allergy Clin Immunol 2007, 120:1223-1225.